5 November 2021
Time zone: GMT +1, CET (Central European Time)
8:30 – 8:40 Opening: Dr. Elisabeth Arrojo
8:40 – 11:05 Session I
- 8:40 – 9:00 Its time for prime time for oncologic hyperthermia/thermotherapy, Prof. Stephan Bodis
- 9:00 – 9:05 discussion
- 9:25 – 9:45 Hyperthermia: a potential game changer in the management of cancers in low-middle-income group countries, Prof. Niloy Ranjan Datta
- 9:45 – 9:50 discussion
- 9:50 – 10:10 Use of the preclinical LabEHY-200 System to compare modulated and unmodulated electromagnetic fields at 13.56 MHz, Dr. Pirus Ghadjar
- 10:10 – 10:15 discussion
- 10:15 – 10:35 Update on mEHT Glio phase III trial. First results and comments, Dr. Elisabeth Arrojo
- 10:35 – 10:40 discussion
- 10:40 – 11:00 Enhancing surface electromagnetic intensity by covering a silver fabric for superficial located tumor treatment during oncothermia, Prof. Kwan-Hwa Chi
- 11:00 – 11:05 discussion
11:05 – 12:05 Break with poster presentations
- 11:12 – 11:17 Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Triple Negative Mouse Breast Cancer, Csaba Schvarz
- 11:19 – 11:24 Inhibition of Triple Negative Breast Cancer (TNBC) growth in a mouse model – Enhancement of modulated electro-hyperthermia (mEHT) effects by heat shock factor-1 (HSF1) or progesterone receptor (PgR) inhibition, Pedro Viana
- 11:26 – 11:31 In vitro and in vivo Study of the Efficacy and toxicity of combination between Modulated electro Hyperthermia and Thermo-sensitive liposomal Doxorubicin in 4T1 Triple negative breast cancer model, Kenan Aloss
- 11:33 – 11:38 Non-steroidal anti-inflammatory drugs (NSAID) enhances the mEHT effect on TNBC (4T1,4T07) and melanoma(B16F10) tumor models, Nino Giunashvili
- 11:40 – 11:45 Modulated electro-hyperthermia induces angiogenic repair in murine triple negative breast cancer model, Mahak Zahra
12:10 – 13:50 Session II
- 12:10 – 12:30 An overview of Oncothermia as a treatment modality for cervical cancer, Dr. Carrie Minaar
- 12:30 – 12:35 discussion
- 12:35 – 12:55 Advanced Pancreatic cancer treated with combo therapy (modulated electro hyperthermia and chemotherapy): a new hope?, Prof. Giammaria Fiorentini
- 12:55 – 13:00 discussion
- 13:00 – 13:20 Synergy between TMZ and individualized multimodal immunotherapy to improve Overall Survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients, Prof. Stefan Van Gool
- 13:20 – 13:25 discussion
- 13:25 – 13:45 Tumors of the hepato-pancreato-biliary system: can we tame the beast?, Dr. Szasz Marcell
- 13:45 – 13:50 discussion
13:50 – 13:55 Closing remarks: Dr. Elisabeth Arrojo